Biphenyl

Biphenyl

SCHEMBL4173337

O=C1NCCO1.c1ccc(-c2ccccc2)cc1

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.39
▸ KDM4E B2RXH2 5/20 0.39
▸ ALDH1A1 P00352 5/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ MAPT P10636 3/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ PARP10 Q53GL7 2/20 0.39
▸ PARP11 Q9NR21 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ USP2 O75604 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ GAA P10253 2/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ NISCH Q9Y2I1 2/20 0.37
▸ TYRO3 Q06418 1/20 0.37
▸ NTRK2 Q16620 1/20 0.37
▸ CLK4 Q9HAZ1 1/20 0.37
▸ DYRK1B Q9Y463 1/20 0.37
▸ CTRC Q99895 1/20 0.36
▸ POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27244229 0.89 FABP6 (0.38) KMT2AKDM4EALDH1A1MEN1MAPT
Benzene SCHEMBL27417324 0.89 FABP6 (0.36) KDM4EALDH1A1MAPTHPGDGAA
Iodobenzene SCHEMBL27431100 0.84 FABP6 (0.33) KMT2AALDH1A1MAPTGAAHSD17B10
Phenol SCHEMBL15020204 0.84 CA12 (0.42) KMT2AFABP6
Toluene SCHEMBL28499248 0.84 TSHR (0.42) KMT2AKDM4EALDH1A1MEN1MAPT
SCHEMBL19171447 0.83 PDE3B (0.46) KDM4EALDH1A1NPC1PARP10PARP11
SCHEMBL969300 0.82 — —
SCHEMBL4621927 0.82 FABP6 (0.35) KDM4EALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL4198 0.82 — —
SCHEMBL80643 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103339116-B Substituted n-valeramide compound, preparation method and application thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2016-04-06 — — CN claimed
CN-103339116-B Substituted n-valeramide compound, preparation method and application thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2016-04-06 — — CN disclosed
US-20090018123-A1 Oxazolidinones Bearing Antimicrobial Activity Composition and Methods of Preparation SINDKHEDKAR MILIND D 2009-01-15 — — US disclosed
EP-1912980-A2 OXAZOLIDINONES BEARING ANTIMICROBIAL ACTIVITY COMPOSITION AND METHODS OF PREPARATION Wockhardt Limited (IN) 2008-04-23 — — EP disclosed
WO-2007023507-A2 OXAZOLIDINONES BEARING ANTIMICROBIAL ACTIVITY COMPOSITION AND METHODS OF PREPARATION WOCKHARDT LIMITED (IN) 2007-03-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018123-A1 Oxazolidinones Bearing Antimicrobial Activity Composition and Methods of Preparation POLL, POLM, POLRMT KMT2A 4128/4885KDM4E 3677/4885ALDH1A1 1847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback